Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Sovereign Pharmaceuticals, LLC
EIR
•Sovereign Pharmaceuticals, LLC•December 19, 2018

Sovereign Pharmaceuticals, LLC – FDA EIR, Dec 19, 2018

Record Details

An FDA inspection of Sovereign Pharmaceuticals, LLC in Fort Worth, TX, conducted from December 11-19, 2018, uncovered six significant violations of current Good Manufacturing Practice (cGMP) regulations. The inspection, a routine cGMP assessment and complaint follow-up, focused on the contract manufacturer of human oral solid and liquid drug products.

Key issues included the firm's Quality Control Unit (QCU) lacking the necessary responsibility and authority to reject all drug products, particularly pilot/exhibit batches, due to the Research and Development department not consistently providing all laboratory data for QCU review. Written procedures for QCU responsibilities were also found to be inadequate regarding the final disposition of these batches. Furthermore, the company failed to thoroughly investigate unexplained discrepancies and batch failures, such as assay failures in bulk and finished products, and permitted unauthorized reprocessing of analytical data by analysts without QCU oversight.

A repeat observation from a previous inspection highlighted the firm's ongoing failure to adhere to its written stability testing program, with numerous drug products exceeding established timeframes for stability test interval completion. Additionally, Sovereign Pharmaceuticals could not provide the raw data and calculations essential for establishing cleaning validation parameters and acceptance limits. Cleaning validation procedures for a critical piece of equipment were also deemed deficient, lacking crucial visual aids like diagrams or photos of swab sampling locations.

In response, Sovereign Pharmaceuticals' management committed to submitting a formal written response to the FDA within 15 business days, outlining proposed corrective actions. The FDA stressed the firm's obligation to comply with all relevant regulations to avoid potential legal sanctions.

Company
Sovereign Pharmaceuticals, LLC
Inspection date
December 19, 2018
Product type
drugs
Office
Dallas District Office
Person
  • Patty P. Kaewussdangkul (Investigator)
View Company Profile

ID · e3176a58-8237-4475-8d1d-f4544b89578f

Violation Codes6
21 CFR 211.166(a)21 CFR 211.67(b)(3)21 CFR 211.22(a)21 CFR 211.19221 CFR 211.194(a)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

Other documents for Sovereign Pharmaceuticals, LLC
  • 483 - 2025-05-12May 12, 2025
  • 483 - 2023-08-02August 2, 2023
  • WARNING_LETTER - 2022-04-22April 22, 2022
  • 483 - 2022-04-22April 22, 2022
  • 483 - 2021-09-01September 1, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sovereign Pharmaceuticals, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.